Literature DB >> 2824024

Colloid carcinoma of the colon and rectum.

B D Minsky1, C Mies, T A Rich, A Recht, J T Chaffey.   

Abstract

To determine the clinicopathologic significance of colloid carcinoma in carcinoma of the colon and rectosigmoid/rectum, a retrospective review of 462 patients who underwent potentially curative surgery at the New England Deaconess Hospital was performed. Seventy-seven patients (17%) were identified who had tumors with some component of colloid present. Colloid carcinoma occurred in 49 (11%). The remaining 28 (6%) had adenocarcinoma with colloid features. Compared to patients with pure adenocarcinoma, the 5-year actuarial survival of patients with colloid carcinoma was lower in the colon, rectosigmoid/rectum, and colorectum. Patterns of failure, expressed as the actuarial incidence of failure at 5 years, were examined by histologic condition and stage. Patients with Dukes' Stage B colloid carcinoma had a higher incidence of total failure, and patients with Dukes' Stage C colloid carcinoma had a higher incidence of local, abdominal, and total failure. None of the differences reached statistical significance. The presence of colloid carcinoma may have a real but small impact on the patterns of failure and survival in colorectal cancer.

Entities:  

Mesh:

Year:  1987        PMID: 2824024     DOI: 10.1002/1097-0142(19871215)60:12<3103::aid-cncr2820601241>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Nuclear expression of claudin-3 in human colorectal adenocarcinoma cell lines and tissues.

Authors:  Yasunori Tokuhara; Tatsuya Morinishi; Toru Matsunaga; Manabu Sakai; Takayoshi Sakai; Hiroyuki Ohsaki; Kyuichi Kadota; Yoshio Kushida; Reiji Haba; Eiichiro Hirakawa
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

2.  Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis.

Authors:  T B Halvorsen; E Seim
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

3.  Prognostic value of expression of sialosyl-Tn antigen in colorectal carcinoma and transitional mucosa.

Authors:  Tohru Nakagoe; Terumitsu Sawai; Takashi Tuji; Masaaki Jibiki; Atushi Nanashima; Hiroyuki Yamaguchi; Toru Yasutake; Hiroyoshi Ayabe; Tatuki Matuo; Yutaka Tagawa
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

4.  Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.

Authors:  S Adluri; F Helling; S Ogata; S Zhang; S H Itzkowitz; K O Lloyd; P O Livingston
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

5.  Overall survival is improved in mucinous adenocarcinoma of the colon.

Authors:  J Hogan; J P Burke; G Samaha; E Condon; D Waldron; P Faul; J Calvin Coffey
Journal:  Int J Colorectal Dis       Date:  2014-01-15       Impact factor: 2.571

6.  Survival with colorectal cancer in ulcerative colitis. A study of 102 cases.

Authors:  A Sugita; A J Greenstein; M B Ribeiro; D B Sachar; C Bodian; A K Panday; A Szporn; J Pozner; T Heimann; M Palmer
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

7.  Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma.

Authors:  Sei-Ichiro Jimi; Masayuki Hotokezaka; Takuto Ikeda; Shuichiro Uchiyama; Hideki Hidaka; Naoki Maehara; Hidenobu Ishizaki; Kazuo Chijiiwa
Journal:  Surg Today       Date:  2014-06-06       Impact factor: 2.549

8.  Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis.

Authors:  R S Bresalier; Y Niv; J C Byrd; Q Y Duh; N W Toribara; R W Rockwell; R Dahiya; Y S Kim
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

9.  Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy.

Authors:  V Catalano; F Loupakis; F Graziano; U Torresi; R Bisonni; D Mari; L Fornaro; A M Baldelli; P Giordani; D Rossi; P Alessandroni; L Giustini; R R Silva; A Falcone; S D'Emidio; S L Fedeli
Journal:  Br J Cancer       Date:  2009-03-03       Impact factor: 7.640

Review 10.  Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications.

Authors:  Monirath Hav; Louis Libbrecht; Liesbeth Ferdinande; Karen Geboes; Piet Pattyn; Claude A Cuvelier
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.